PFM Health Sciences’s Tango Therapeutics TNGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-326,047
Closed -$10.2M – 122
2026
Q2
$10.2M Sell
326,047
-80,198
-20% -$1.98M 0.87% 42
2026
Q1
$8.5M Buy
+406,245
New +$5.65M 0.77% 44

Other funds holding TNGX

PFM Health Sciences's TNGX Position: Q3 2026 in Review

PFM Health Sciences sold out of Tango Therapeutics (TNGX) in Q3 2026, closing a stake of 326,047 shares — an estimated $10.2M sold.

PFM Health Sciences first reported a position in TNGX in Q1 2026 and held it in 2 quarters. The position peaked at $10.2M in Q2 2026. 211 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.

  • PFM Health Sciences reported no remaining Tango Therapeutics position as of Q3 2026 after selling out during the quarter.
  • PFM Health Sciences sold 326,047 Tango Therapeutics shares in Q3 2026, an estimated $10.2M.
  • PFM Health Sciences first reported a position in Tango Therapeutics in Q1 2026 and held it in 2 quarters.
  • PFM Health Sciences's Tango Therapeutics position peaked at $10.2M in Q2 2026.
  • 211 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.

Based on PFM Health Sciences's 13F filing for Q3 2026, filed 16 Nov 2026.